New Releases from NCBI BookshelfTislelizumab for treating advanced non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal).​Tislelizumab for treating advanced non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal).